86
Views
5
CrossRef citations to date
0
Altmetric
Review

Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options

&
Pages 15-24 | Published online: 16 Feb 2015

References

  • WaiselYEshelAKeynanNLanggutDAmbrosia: a new impending disaster for the Israeli allergic populationIsr Med Assoc J2008101285685719160941
  • ZiskaLKnowltonKRogersCRecent warming by latitude associated with increased length of ragweed pollen season in central North AmericaProc Natl Acad Sci U S A2011108104248425121368130
  • ZiskaLHGebhardDEFrenzDAFaulknerSSingerBDStrakaJGCities as harbingers of climate change: common ragweed, urbanization, and public healthJ Allergy Clin Immunol2003111229029512589347
  • RidoloEAlbertiniRGiordanoDSolianiLUsbertiIDall’AglioPPAirborne pollen concentrations and the incidence of allergic asthma and rhinoconjunctivitis in northern Italy from 1992 to 2003Int Arch Allergy Immunol2007142215115717057413
  • ChapmanDSHaynesTBealSEsslFBullockJMPhenology predicts the native and invasive range limits of common ragweedGlob Chang Biol201420119220224038855
  • ThibaudonMColonnelloCBesancenotJPTolobaYFrançoisHCaillaudDCan birdseed contribute to the spread of ragweed?J Investig Allergol Clin Immunol2012223234236
  • KasprzykINon-native Ambrosia pollen in the atmosphere of Rzeszów (SE Poland); evaluation of the effect of weather conditions on daily concentrations and starting dates of the pollen seasonInt J Biometeorol200852534135118046583
  • StachASmithMSkjøthCABrandtJExamining Ambrosia pollen episodes at Poznań (Poland) using back-trajectory analysisInt J Biometeorol200751427528617120063
  • CecchiLLorenzoCMorabitoMLong distance transport of ragweed pollen as a potential cause of allergy in central ItalyAnn Allergy Asthma Immunol2006961869116440538
  • PucMRagweed pollen in the air of SzczecinAnn Agric Environ Med2004111535715236498
  • DharajiyaNBoldoghICardenasVSurSRole of pollen NAD(P) H oxidase in allergic inflammationCurr Opin Allergy Clin Immunol200881576218188019
  • GunawanHTakaiTIkedaSOkumuraKOgawaHProtease activity of allergenic pollen of cedar, cypress, juniper, birch and ragweedAllergol Int2008571839118209508
  • GadermaierGDedicAObermeyerGFrankSHimlyMFerreiraFBiology of weed pollen allergensCurr Allergy Asthma Rep20044539140015283880
  • LéonardRWopfnerNPabstMA new allergen from ragweed (Ambrosia artemisiifolia) with homology to art v 1 from mugwortJ Biol Chem201028535271922720020576600
  • RadauerCNandyAFerreiraFUpdate of the WHO/IUIS Allergen Nomenclature Database based on analysis of allergen sequencesAllergy201469441341924738154
  • MariARasiCPalazzoPScalaEAllergen databases: current status and perspectivesCurr Allergy Asthma Rep20099537638319671381
  • RogersBLPollockJKlapperDGGriffithIJSequence of the proteinase-inhibitor cystatin homologue from the pollen of Ambrosia artemisiifolia (short ragweed)Gene199313322192217916719
  • PopovicMMMilovanovicMBurazerLCysteine proteinase inhibitor Act d 4 is a functional allergen contributing to the clinical symptoms of kiwifruit allergyMol Nutr Food Res201054337338019885843
  • GadermaierGWopfnerNWallnerMArray-based profiling of ragweed and mugwort pollen allergensAllergy200863111543154918925891
  • EggerMMutschlechnerSWopfnerNGadermaierGBrizaPFerreiraFPollen-food syndromes associated with weed pollinosis: an update from the molecular point of viewAllergy200661446147616512809
  • AseroRWopfnerNGruberPGadermaierGFerreiraFArtemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition?Clin Exp Allergy200636565866516650052
  • GergenPJTurkeltaubPCKovarMGThe prevalence of allergic skin test reactivity to eight common aeroallergens in the US population: results from the second National Health and Nutrition Examination SurveyJ Allergy Clin Immunol19878056696793680811
  • ArbesSJJrGergenPJElliottLZeldinDCPrevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination SurveyJ Allergy Clin Immunol2005116237738316083793
  • BurbachGJHeinzerlingLMRöhneltCBergmannKCBehrendtHZuberbierTGA(2)LEN studyRagweed sensitization in Europe – GA(2)LEN study suggests increasing prevalenceAllergy200964466466519210367
  • BoehmeMWGabrioTDierkesmannRSensitization to airborne ragweed pollen – a cause of allergic respiratory diseases in Germany?Dtsch Med Wochenschr200913428–2914571463 German19572244
  • BoehmeMWKompauerIWeidnerUPiechotowskiIGabrioTBehrendtHRespiratory symptoms and sensitization to airborne pollen of ragweed and mugwort of adults in Southwest GermanyDtsch Med Wochenschr20131383316511658 German23913351
  • RuëffFPrzybillaBWalkerASensitization to common ragweed in southern Bavaria: clinical and geographical risk factors in atopic patientsInt Arch Allergy Immunol20121591657422572962
  • CanisMBeckerSGrögerMKramerMFIgE reactivity patterns in patients with allergic rhinoconjunctivitis to ragweed and mugwort pollensAm J Rhinol Allergy2012261313522391077
  • TosiAWüthrichBBoniniMPietragalla-KöhlerBTime lag between Ambrosia sensitisation and Ambrosia allergy: a 20-year study (1989–2008) in Legnano, northern ItalySwiss Med Wkly2011141w1325321984071
  • TestiSCarabelliACecchiLMulticenter investigation to assess the prevalence of ambrosia pollen allergy in TuscanyJ Investig Allergol Clin Immunol2009193251252
  • Ackermann-LiebrichUSchindlerCFreiPSensitisation to Ambrosia in Switzerland: a public health threat on the waitSwiss Med Wkly20091395–6707519204839
  • KimJHOhJWLeeHBChanges in sensitization rate to weed allergens in children with increased weeds pollen counts in Seoul metropolitan areaJ Korean Med Sci201227435035522468096
  • OberhuberCMaYWopfnerNPrevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patientsInt Arch Allergy Immunol200814529410117823540
  • HanDLaiXGjesingBZhongNZhangLSpangfortMDThe specific IgE reactivity pattern of weed pollen-induced allergic rhinitis patientsActa Otolaryngol2011131553353821189055
  • JarvisDNewsonRLotvallJAsthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in EuropeAllergy2012671919822050239
  • BaroodyFMMuchaSMdeTineoMNaclerioRMEvidence of maxillary sinus inflammation in seasonal allergic rhinitisOtolaryngol Head Neck Surg2012146688088622301108
  • BaroodyFMMuchaSMDetineoMNaclerioRMNasal challenge with allergen leads to maxillary sinus inflammationJ Allergy Clin Immunol2008121511261132 e718367240
  • GungorAHouserSMAquinoBFA comparison of skin endpoint titration and skin-prick testing in the diagnosis of allergic rhinitisEar Nose Throat J2004831546014986760
  • JiangXDLiGYDongZZhuDDCorrelation analysis of two serum-specific immunoglobulin E test systems and skin-prick test in allergic rhinitis patients from northeast ChinaAm J Rhinol Allergy201125211611921294972
  • AlexanderMPatelPAllegroSHicksASupplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitisClin Experiment Ophthalmol200331320621212786770
  • DruceHMPerformance impairment revisitedAnn Allergy Asthma Immunol200289434434512392375
  • WilkenJABerkowitzRKaneRDecrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitisAnn Allergy Asthma Immunol200289437238012392381
  • WilkenJAKaneRLEllisAKA comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitisAnn Allergy Asthma Immunol200391437538514582817
  • PatelPRolandPSMarpleBFAn assessment of the onset and duration of action of olopatadine nasal sprayOtolaryngol Head Neck Surg2007137691892418036421
  • RatnerPHHampelFCAmarNJSafety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedarAnn Allergy Asthma Immunol200595547447916312171
  • MeltzerEOHampelFCRatnerPHSafety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitisAnn Allergy Asthma Immunol200595660060616400902
  • PatelPPatelDEfficacy comparison of levocetirizine vs montelukast in ragweed sensitized patientsAnn Allergy Asthma Immunol2008101328729418814452
  • MoinuddinRdeTineoMMaleckarBNaclerioRMBaroodyFMComparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitisAnn Allergy Asthma Immunol2004921737914756468
  • JuniperEFGuyattGHDevelopment and testing of a new measure of health status for clinical trials in rhinoconjunctivitisClin Exp Allergy199121177832021881
  • DayJHBriscoeMPRatzJDDanzigMYaoREfficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unitAnn Allergy Asthma Immunol2009102432833819441605
  • KaiserHBNaclerioRMGivenJTolerTNEllsworthAPhilpotEEFluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitisJ Allergy Clin Immunol200711961430143717418384
  • ProudDRikerDKTogiasAReproducibility of nasal allergen challenge in evaluating the efficacy of intranasal corticosteroid treatmentClin Exp Allergy201040573874420337650
  • MironeCAlbertFTosiAEfficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled studyClin Exp Allergy20043491408141415347374
  • CanonicaGWPassalacquaGNoninjection routes for immunotherapyJ Allergy Clin Immunol20031113437448 ; quiz 44912642818
  • LeathermanBDOwenSParkerMSublingual Immunotherapy: Past, present, paradigm for the future? A review of the literatureOtolaryngol Head Neck Surg20071363 SupplS1S2017321336
  • CoxLSLarenas LinnemannDNolteHWeldonDFinegoldINelsonHSSublingual immunotherapy: a comprehensive reviewJ Allergy Clin Immunol200611751021103516675328
  • AndréCPerrin-FayolleMGrosclaudeMA double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationshipInt Arch Allergy Immunol2003131211111812811019
  • SkonerDGentileDBushRFasanoMBMcLaughlinAEschRESublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollenJ Allergy Clin Immunol20101253660666, 666. e1–e666. e420153030
  • BowenTGreenbaumJCharbonneauYCanadian trial of sub-lingual swallow immunotherapy for ragweed rhinoconjunctivitisAnn Allergy Asthma Immunol200493542543015562880
  • NolteHHébertJBermanGRandomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adultsAnn Allergy Asthma Immunol20131106450456 e423706715
  • CreticosPSMaloneyJBernsteinDIRandomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adultsJ Allergy Clin Immunol2013131513421349 e623622121
  • SimardMJBenoitDLEffect of repetitive mowing on common ragweed (Ambrosia artemisiifolia L.) pollen and seed productionAnn Agric Environ Med2011181556221736270
  • GajnikDPeternelRMethods of intervention in the control of ragweed spread (Ambrosia artemisiifolia L.) in the area of Zagreb County and the city of ZagrebColl Antropol20093341289129420102083
  • LaaidiMLaaidiKBesancenotJPThibaudonMRagweed in France: an invasive plant and its allergenic pollenAnn Allergy Asthma Immunol200391219520112952115
  • PeternelRMusic MilanovicSSrnecLAirborne ragweed (Ambrosia artemisiifolia L.) pollen content in the city of Zagreb and implications on pollen allergyAnn Agric Environ Med200815112513018581990
  • SikoparijaBRadisicPPejakTSimicSAirborne grass and ragweed pollen in the southern Panonnian Valley – consideration of rural and urban environmentAnn Agric Environ Med200613226326617195999
  • CsépeZMakraLVoukantsisDPredicting daily ragweed pollen concentrations using Computational Intelligence techniques over two heavily polluted areas in EuropeSci Total Environ2014476–477542552
  • HowardLELevetinEAmbrosia pollen in Tulsa, Oklahoma: aerobiology, trends, and forecasting model developmentAnn Allergy Asthma Immunol2014113664164625240331
  • LaaidiMThibaudonMBesancenotJPTwo statistical approaches to forecasting the start and duration of the pollen season of Ambrosia in the area of Lyon (France)Int J Biometeorol2003482657312783292
  • JacobsRLHarperNHeWResponses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypesJ Allergy Clin Immunol20121301122127 e822554707
  • KoreckAICsomaZBodaiLRhinophototherapy: a new therapeutic tool for the management of allergic rhinitisJ Allergy Clin Immunol2005115354154715753902
  • GaracziEBoros-GyeviMBellaZCsomaZKeményLKoreckAIntranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis: results of a pilot studyPhotochem Photobiol201187247447721366599
  • CsomaZKoreckAIgnaczFPUVA treatment of the nasal cavity improves the clinical symptoms of allergic rhinitis and inhibits the immediate-type hypersensitivity reaction in the skinJ Photochem Photobiol B2006831212616406552
  • O’MearaTJSercombeJKMorganGReddelHKXuanWToveyERThe reduction of rhinitis symptoms by nasal filters during natural exposure to ragweed and grass pollenAllergy200560452953215727589
  • BarchukWTSalapatekAMGeTD’AngeloPLiuXA proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestionJ Allergy Clin Immunol20131324838846 e1–e623791513
  • StokesJRRomeroFAJrAllanRJThe effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptomsJ Allergy Clin Immunol20121292409412, 412. e1–e222196768
  • AndohTSakaiKUrashimaMKitazawaKHonmaAKuraishiYInvolvement of leukotriene B4 in itching in a mouse model of ocular allergyExp Eye Res2012989710322504036
  • StebbinsKJBroadheadARMusiyenkoADP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virusInt Arch Allergy Immunol2012157325926822042170
  • CasaleTBStokesJRImmunotherapy: what lies beyondJ Allergy Clin Immunol20141333612619 : quiz 62024581428
  • AryanZHolgateSTRadziochDRezaeiNA new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthmaInt Arch Allergy Immunol20141641466324853609
  • ChangTWShiungYYAnti-IgE as a mast cell-stabilizing therapeutic agentJ Allergy Clin Immunol2006117612031212 ; quiz 121316750976
  • LinHBoeselKMGriffithDTOmalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophilsJ Allergy Clin Immunol2004113229730214767445
  • SainiSBloomDCBienemanAVasagarKTogiasASchroederJSystemic effects of allergen exposure on blood basophil IL-13 secretion and FcepsilonRIbetaJ Allergy Clin Immunol2004114476877415480314
  • PrussinCGriffithDTBoeselKMLinHFosterBCasaleTBOmalizumab treatment downregulates dendritic cell FcepsilonRI expressionJ Allergy Clin Immunol200311261147115414657874
  • CasaleTBBusseWWKlineJNImmune Tolerance Network GroupOmalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitisJ Allergy Clin Immunol2006117113414016387596
  • KlunkerSSaggarLRSeyfert-MargolisVImmune Tolerance Network GroupCombination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen bindingJ Allergy Clin Immunol2007120368869517631952
  • FariaRMcKennaCPalmerSOptimizing the position and use of omalizumab for severe persistent allergic asthma using cost- effectiveness analysisValue Health201417877278225498772
  • HayashiTRazETLR9-based immunotherapy for allergic diseaseAm J Med200611910897 e1–e617000223
  • NayakASTripathyILevittDNovel Amb a 1 CpG oligodeoxy-ribonucleotide conjugate ragweed vaccine administered to childrenJ Allergy Clin Immunol20061172 SupplS159
  • SimonsFEShikishimaYVan NestGEidenJJHayGlassKTSelective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNAJ Allergy Clin Immunol200411361144115115208597
  • SimonsFEHayGlassKTImmunotherapy with a ragweed vaccineN Engl J Med200735618687 ; author reply 8717205611
  • AsaiKFoleySCSumiYAmb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitisAllergol Int200857437738118797179
  • TulicMKChristodoulopoulosPFisetPOLocal induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjectsAllergol Int200958456557219776676
  • TulicMKFisetPOChristodoulopoulosPAmb a 1- immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory responseJ Allergy Clin Immunol2004113223524114767435
  • CreticosPSSchroederJTHamiltonRGImmune Tolerance Network GroupImmunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitisN Engl J Med2006355141445145517021320
  • BaldrickPRichardsonDWoronieckiSRLeesBPollinex Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL) for the treatment of ragweed pollen allergyJ Appl Toxicol200727439940917299813
  • PatelPHoldichTFischer von Weikersthal-DrachenbergKJHuberBEfficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollenJ Allergy Clin Immunol20141331121129 e1–e223870670
  • FukushimaASumiTFukudaKKumagaiNNishidaTUenoHEndogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitisInt Arch Allergy Immunol20071441798417505142
  • FukushimaASumiTFukudaKInterleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phaseBr J Ophthalmol200690121535154116914468
  • El BassamSPinsonneaultSKornfeldHRenFMenezesJLabergeSInterleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cellsImmunology20061171899616423044
  • OzakiASekiYFukushimaAKuboMThe control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine modelJ Immunol200517585489549716210657
  • MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200967e100009719621072